Please assess the completion status of the following clinical trial:

Trial Title: Dexamethasone Infusion in Community-acquired Pneumonia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~Patients aged 18 to 100 years with a community-acquired pneumonia.~Criteria to determine a community-acquired pneumonia:~* Chest radiograph showing new opacities~* In combination with two of the following findings:~  * Cough~ * Production of sputum~ * Temp \>38,0 °C or \<36,0 °C~ * Audible abnormalities by chest examination compatible with pneumonia~ * Leukocytosis (\>10.000 cells/mm3), leftward shift (\>10%) or leukopenia (\<4000 cells/mm3)~ * CRP \> 15 mg/dl (three times upper limit of normal)~Exclusion Criteria:~* o The following groups are excluded:~  * Immunocompromised patients:~    * Patients with a known congenital or achieved immunodeficiency.~   * Patients who received chemotherapy less than 6 weeks ago.~   * Patients who received corticosteroids in the last 6 weeks.~   * Patients who received immunosuppressive medication in the last 6 weeks. (like cyclosporine, cyclofosfamide, azathioprine)~   * Patients with COPD who are on systemic corticosteroids for COPD.~   * Patients who require ICU treatment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): dexamethasone
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).